| Literature DB >> 24561791 |
Boris Kovacic1, Andrea Hoelbl-Kovacic2, Katrin M Fischhuber3, Nicole R Leitner3, Dagmar Gotthardt2, Emilio Casanova4, Veronika Sexl2, Mathias Müller5.
Abstract
Considerable effort has been expended to identify genes that account for myeloid lineage commitment and development. However, currently available non-invasive mouse models utilize myeloid-specific reporters that are significantly expressed in hematopoietic stem cells as well as lymphoid compartments. Here, we describe a myeloid-specific marker that is not shared by any other lineage. We show that lactotransferrin mRNA is expressed by Gr-1(+)/CD11b(+) cells in the bone marrow, as opposed to hematopoietic stem cells or any peripheral cell population. To follow the progeny of lactotransferrin-expressing bone marrow cells, we generated a mouse model in which a reporter gene is irreversibly activated from the lactotransferrin-promoter. We found that lactotransferrin-reporter labels a majority of neutrophils, monocytes, macrophages and distinct subtypes of dendritic cells, while excluding T, B, natural killer cells, interferon-producing killer dendritic cells, plasmacytoid dendritic cells, erythrocytes and eosinophils. Lactotransferrin-reporter(-) bone marrow cells retain lymphoid, erythroid and long-term repopulating potential, while lactotransferrin-reporter(+) bone marrow cells confer only myeloid, but not lymphoid potential. We conclude that lactotransferrin represents a late stage differentiation marker of neutrophils, macrophages and distinct subtypes of dendritic cells. Copyright© Ferrata Storti Foundation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24561791 PMCID: PMC4040904 DOI: 10.3324/haematol.2013.097154
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941